⌕
Madrigal Pharmaceuticals · MDGL · Nasdaq
Tenet 32 · Weak
Compare
$421.99−0.46%At closeTenet 32 · Weak
$421.99−1.97 (−0.46%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Madrigal Pharmaceuticals (MDGL) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● PRNewsWireNov 17, 2026 · 20:12 ET
MDGL Investigation Reminder: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa., Nov. 17, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws b…

● Seeking AlphaNov 17, 2026 · 08:12 ET
Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Jefferies Global Healthcare Conference 2026 Transcript…

● Newsfile CorpNov 17, 2026 · 04:45 ET
Kaplan Fox Notifies Madrigal Pharmaceuticals, Inc. (MDGL) Investors of a Securities Investigation into the Company

New York, New York--(Newsfile Corp. - November 17, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") (NASDAQ: MDGL). CLIC…

● GlobeNewsWireNov 16, 2026 · 13:30 ET
Kaplan Fox Reminds Investors of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) to Contact the Firm Regarding an Investigation of Potential Securities Law Violations

NEW YORK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. (“Madrigal” or the “Company”) (NASDAQ: MDGL). CLICK HERE TO RECEI…

● Newsfile CorpNov 16, 2026 · 04:30 ET
Kaplan Fox is Investigating Madrigal Pharmaceuticals, Inc. (MDGL) on Behalf of Investors for Potential Securities Law Violations

New York, New York--(Newsfile Corp. - November 16, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") (NASDAQ: MDGL). CLIC…

● GlobeNewsWireNov 14, 2026 · 12:05 ET
MDGL Investigation Notification: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa., Nov. 14, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities la…

● GlobeNewsWireNov 13, 2026 · 18:00 ET
Kaplan Fox is Investigating Claims on Behalf of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Investors for Potential Securities Law Violations

NEW YORK, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. (“Madrigal” or the “Company”) (NASDAQ: MDGL). CLICK HERE TO RECEI…

● Newsfile CorpNov 13, 2026 · 13:00 ET
Kaplan Fox is Investigating Madrigal Pharmaceuticals, Inc. (MDGL) and Encourages Investors Who Suffered Losses to Contact the Firm

New York, New York--(Newsfile Corp. - November 13, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") (NASDAQ: MDGL). CLIC…

● GlobeNewsWireNov 13, 2026 · 08:00 ETCOMPANY'S OWN WORDS
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences

CONSHOHOCKEN, Pa., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences:…

● Newsfile CorpNov 12, 2026 · 05:05 ET
Kaplan Fox & Kilsheimer LLP Announces an Investigation into Madrigal Pharmaceuticals, Inc. (MDGL) for Possible Securities Law Violations

New York, New York--(Newsfile Corp. - November 12, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") (NASDAQ: MDGL). CLIC…

● PRNewsWireNov 11, 2026 · 20:38 ET
Investigation of MDGL Reminder: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa., Nov. 11, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws b…

● GlobeNewsWireNov 11, 2026 · 13:35 ET
Kaplan Fox Encourages Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Investors to Contact the Firm Regarding an Investigation of Possible Securities Law Violations

NEW YORK, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. (“Madrigal” or the “Company”) (NASDAQ: MDGL). CLICK HERE TO RECEI…

● Business WireNov 11, 2026 · 10:00 ET
MADRIGAL PHARMACEUTICALS, INC. MDGL INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 8.1% Share Drop

NEW YORK--(BUSINESS WIRE)---- $MDGL #ClassActionLawsuit--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Madrigal Pharmaceuticals, Inc. (“Madrigal” or the “Company”) (NASDAQ: MDGL)…

● PRNewsWireNov 11, 2026 · 08:39 ET
MDGL INVESTIGATION NOTICE: Hagens Berman, National Securities Law Firm, Investigating Madrigal Pharmaceuticals (NASDAQ: MDGL) Following Whistleblower Allegations of Clinical Data Integrity Concerns

/PRNewswire/ -- Hagens Berman, a national complex securities litigation law firm, announces an investigation into Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL)…

● Newsfile CorpNov 11, 2026 · 04:50 ET
Kaplan Fox Encourages Investors of Madrigal Pharmaceuticals, Inc. (MDGL) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - November 11, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") (NASDAQ: MDGL). CLIC…

● Zacks Investment ResearchNov 10, 2026 · 10:16 ET
4 Commercial-Stage Biotechs Poised for Sustained Revenue Growth

TGTX, BCRX, INSM and MDGL are expanding product sales through rising demand, broader patient access and new market opportunities.…

● Newsfile CorpNov 10, 2026 · 04:35 ET
Kaplan Fox Alerts Madrigal Pharmaceuticals, Inc. (MDGL) Investors to an Investigation of Potential Securities Law Violations

New York, New York--(Newsfile Corp. - November 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") (NASDAQ: MDGL). CLIC…

● GlobeNewsWireNov 9, 2026 · 13:20 ET
Kaplan Fox Alerts Investors of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) to an Ongoing Investigation of Possible Securities Law Violations

NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. (“Madrigal” or the “Company”) (NASDAQ: MDGL). CLICK HERE TO RECEI…

● Defense WorldNov 9, 2026 · 05:11 ET
Madrigal Pharmaceuticals, Inc. $MDGL Stock Position Lessened by Candriam S.C.A.

Candriam S.C.A. trimmed its position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) by 4.5% during a recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. T…

● Newsfile CorpNov 9, 2026 · 04:20 ET
Kaplan Fox Announces a Securities Investigation into Madrigal Pharmaceuticals, Inc. (MDGL) - Investors Encouraged to Contact the Firm

New York, New York--(Newsfile Corp. - November 9, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") (NASDAQ: MDGL). CLICK…

● Business WireNov 8, 2026 · 23:38 ET
MDGL Investors Have Opportunity to Join Madrigal Pharmaceuticals, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $MDGL--MDGL Investors Have Opportunity to Join Madrigal Pharmaceuticals, Inc. Fraud Investigation with SBS Law.…

● GlobeNewsWireNov 7, 2026 · 11:41 ET
MDGL Investigation Reminder: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa., Nov. 07, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities la…

● PRNewsWireNov 6, 2026 · 20:07 ET
Notice of Investigation of MDGL: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa., Nov. 6, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by…

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

NVDA33−0.4%
DLB4−3.8%
WDAY4−5.8%

Article counts from the last market-wide feed page, across every symbol we track and not just MDGL · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.